Journal
INFECTIOUS DISEASES OF POVERTY
Volume 7, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s40249-018-0406-7
Keywords
Onchocerciasis; Control; Elimination; Monitoring & evaluation; Community drug distributors; Epilepsy; Prevalence; Incidence
Categories
Funding
- European Research Council (ERC) [671055]
- Wellcome Trust [085133/Z/08/Z, 092677/Z/10/Z]
- Wellcome Trust [085133/Z/08/Z, 092677/Z/10/Z] Funding Source: Wellcome Trust
Ask authors/readers for more resources
Background: An estimated 25 million people are currently infected with onchocerciasis (a parasitic infection caused by the filarial nematode Onchocerca volvulus and transmitted by Simulium vectors), and 99% of these are in sub-Saharan Africa. The African Programme for Onchocerciasis Control closed in December 2015 and the World Health Organization has established a new structure, the Expanded Special Project for the Elimination of Neglected Tropical Diseases for the coordination of technical support for activities focused on five neglected tropical diseases in Africa, including onchocerciasis elimination.& para;& para;Aims: In this paper we argue that despite the delineation of a reasonably well-defined elimination strategy, its implementation will present particular difficulties in practice. We aim to highlight these in an attempt to ensure that they are well understood and that effective plans can be laid to solve them by the countries concerned and their international partners.& para;& para;Conclusions: A specific concern is the burden of disease caused by onchocerciasis-associated epilepsy in hyperendemic zones situated in countries experiencing difficulties in strengthening their onchocerciasis control programmes. These difficulties should be identified and programmes supported during the transition from morbidity control to interruption of transmission and elimination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available